Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Zentek Ltd V.ZEN

Alternate Symbol(s):  ZTEK

Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.


TSXV:ZEN - Post by User

Bullboard Posts
Post by mark5698on Nov 19, 2002 6:36pm
174 Views
Post# 5597228

Zenon posts ...

Zenon posts ...... profitable third quarter with record revenue and growing backlog Trading Symbol: ZEN and ZEN.A on The Toronto Stock Exchange OAKVILLE, ON, Nov. 19 /CNW/ - ZENON, the membrane technology leader in water treatment, closed the third quarter ending September 30, 2002 with a 14% increase in both revenue and profit over the same quarter as last year. << Financial Highlights -------------------- For the three and nine months ended September 30: Three months Nine months 2002 2001 2002 2001 ------------------------------------------------------------------------- ($ 000's) Revenue 36,577 32,216 93,567 85,081 Operating income before income taxes 3,329 2,634 2,460 3,838 Net earnings 2,443 2,134 1,786 2,469 ------------------------------------------------------------------------- Net earnings per share - basic $0.10 $0.09 $0.07 $0.10 ------------------------------------------------------------------------- Revenue of $37 million was an increase of $9 million over the second quarter 2002. On a year-to-date basis, revenue of $94 million was 10% higher compared to the previous year. Net earnings of $2.4 million, or $0.10 per share, are also up from the third quarter of 2001. The company's operating profit of $3 million is recorded as the best to date for the quarter and is up 26% over the third quarter of last year. "ZENON continues to set record backlog levels and the third quarter is no exception," said Andrew Benedek, Chairman and Chief Executive Officer of ZENON. "I am happy to report that our backlog stands at $137 million at the end of September 2002, a 14% improvement from a year ago. Highlights of the Quarter ------------------------- During the quarter, ZENON received approximately $45 million in new orders, the majority of which came from North America. Among them is the retrofit and upgrade of an existing wastewater treatment plant in Tucson, Arizona. The Randolph Park Wastewater Reclamation Facility will treat wastewater to be reused for irrigation. In an effort to conserve the supply of potable water, the reclamation facility will supplement the community's existing water supplies that are used specifically for watering lawns and golf courses. Valued at approximately $6 million, the new wastewater treatment plant is expected to be complete by November 2003. Residents of the Town of Collingwood, Ontario and neighbouring communities have been enjoying water treated by ZeeWeed(R) membranes since 1998. Due to an increase in demand, the Town has decided to expand the existing facility with the purchase of ZENON's latest technology, the ZeeWeed(R) 1000. This new addition will augment current drinking water capacity to produce nearly 9 million gallons of pure, safe water per day. In addition to the above, ZENON has been selected by the Municipality of Port Hope to provide its ZeeWeed(R) 1000 technology for a new drinking water plant that will be sized to produce 7 million gallons of water per day. Currently, ZENON has been awarded the first phase consisting of an engineering design contract. Once completed in 2003, this will bring the number of ZENON technology plants in Ontario to 24. As has been stated in previous announcements, ZENON's pipeline is full of orders for which the company is working on the engineering design or has received a Letter of Intent acknowledging that it has been pre-selected. The current value of these projects is in excess of $100 million and the company is confident that it will be awarded the formal purchase orders over the next several months. ZENON continues to maintain its lead in the municipal wastewater market globally. During the quarter, the company announced that construction would start on North America's largest membrane wastewater treatment plant, to be built in Traverse City, Michigan. "We are seeing a progressive increase in plant sizes as rates of adoption increase," said Mr. Benedek. "A year ago, there were no MBR (membrane bioreactor) plants treating more than 8 million gallons of wastewater per day. There are now three plants larger than 8 million gallons per day all using ZENON's MBR system." The company's European business is also on the rise with $16 million in new orders booked during the quarter. In addition to winning the contract to build the largest European membrane boiler feed plant in Hungary, the company has received two orders in Holland; one to treat municipal sewage, the other to treat wastewater for a meat processing plant. At the beginning of the year, construction began on ZENON's new manufacturing plant in Hungary. On November 13, 2002 the new facility was officially opened and has already commenced membrane production. The plant will initially double ZENON's current membrane capacity and is built to accommodate future growth as required. It was announced during the quarter that Homespring, ZENON's new whole home product, received NSF certification and is now available through Enbridge Home Services in the Greater Toronto Area, Ottawa and the Muskoka region. NSF is North America's most accepted and respected certification body for public health and safety. The Homespring UF 100 can be installed in any home and will instantly provide cleaner, better tasting water for the entire home. Although the initial launch is in Ontario, ZENON expects to market this unique product throughout Canada and the United States over the next year. ZENON has been acknowledged for its achievements in a number of areas this year, most notable of which are: - Canada's Exporter of the Year presented by the Department of Foreign Affairs and International Trade, acknowledging ZENON's success and achievements beyond Canada's borders - Canadian Innovation Award for Sustainable Development presented by the Canadian Manufacturers & Exporters, recognizing innovative excellence in developing new technology as it relates to environmental improvement - Outstanding Business Achievement Award presented by the Ontario Chamber of Commerce, ZENON is the only company that has received this award twice, the first was in 1998 - Canada's Top Corporate Citizen presented by Corporate Knights acknowledging ZENON's level of corporate social responsibility - 2002 Product Achievement Award presented by Filtration & Separation magazine for the development of the ZeeWeed(R) 1000 membrane - Technology of the Year presented by Frost & Sullivan, recognizing ZENON's outstanding achievements in technology development - For the third consecutive year, ZENON has been recognized as one of Canada's Top 100 Employers Management Discussion and Analysis ---------------------------------- Revenue at $37 million set a record for third quarter revenue in the Corporation. Revenue is 14% higher than the third quarter of 2001 and 10% higher on a year-to-date basis. The North American market has provided the majority of the revenue growth in the quarter at 19% compared to the previous year. On a year-to-date basis, North America revenue has increased 8.2% and Europe, Middle East and Asia combined have increased 16.1% over the previous year. Complementing revenue growth was the increase in the company's backlog to $137 million based on $45 million of new orders booked in the month. Gross profit for the third quarter is 38.4%, just slightly below that for the third quarter a year ago. Improvements in gross profit can be seen throughout 2002 where the year-to-date figure of 34.7% for the nine months ended September 30 was up from 32.3% for the six months ended June 30. This reflects improvements in production as well as efficiencies in membrane manufacturing and product mix. Selling, general and administrative (SG&A) expense is 23.6% of revenue for the quarter and 25.4% of revenue on a year-to-date basis. Depreciation and Amortization at $2.3 million is consistent with the previous quarter and continues to reflect the ongoing investment in membrane technology and capacity. Net interest was an income of $236,000 in the quarter and $531,000 year-to-date, compared to an expense of $378,000 and $1,613,000 respectively, as a result of ZENON's equity issue in the first quarter of 2002. Operating income of $3.3 million represents a record quarter for operating income before one-time adjustments for the company and was $0.7 million higher than last year. The year-to-date operating profit of $2.5 million, which remains below last year's result of $3.8 million, reflects the strategic Singapore order impact in the second quarter. The effective tax rate of 26.6% for the quarter and 27.4% for the year and the decrease in future tax assets reflects the geographical distribution of the income. This resulted in a net income for the quarter of $2.4 million ($0.10 per share), compared to $2.1 million last year. On a year-to-date basis, net income was $1.8 million ($0.07 per share) compared to $2.5 million ($0.10 per share) for the previous year. Capital Expenditure and Liquidity --------------------------------- In February 2002, ZENON completed the sale of two million non-voting Class A shares and one million common shares for aggregate proceeds of $42.5 million. A portion of these proceeds was used to repay the revolving term facility of $10 million and the balance to finance capital expenditures. Capital expenditures in property plant and equipment of $11.5 million in the quarter and $35.8 million for the year represent the company's continued investment in proprietary membrane technology. The major areas of expenditure were the continued construction of ZENON's new membrane manufacturing facility in Hungary, the upgrade of ZENON's membrane manufacturing plant in Burlington, Ontario, the development of production capacity for Homespring and the ongoing investment in pilot costs to enable the company to further promote its products in the marketplace. Operating activities used $1.4 million in cash in the quarter compared to generating $11.3 million on a year-to-date basis. The utilization of cash resulted from the funding of working capital to support the increase in revenue. Management continues to focus on working capital management and improving cash utilization. Increased activity for ZENON's European operations has necessitated the maintenance of cash balances to offset a portion of guarantees issued to customers, which are part of the normal course of business in Europe. As a result, restricted cash has increased $900,000 in the quarter and $3.1 million on a year-to-date basis. Overall, the company continues to be in a strong financial position to support growth with cash and cash equivalents of $8.6 million at the end of the quarter. Accounting Policies ------------------- The Consolidated Financial Statements have been prepared using the same accounting policies as described in the Company's 2001 annual report, except for the following items: Effective January 1, 2002 ZENON adopted the Canadian Institute of Chartered Accountants (CICA) recommendations for the measurement, presentation and disclosure of goodwill. Goodwill is no longer amortized, but is tested at least annually for impairment. Goodwill will not be amortized in 2002. In accordance with the recommendation, the change in accounting policy is not applied retroactively. If goodwill had not been amortized in 2001, net earnings for the third quarter would have increased by $69,000 and for the first nine months of 2001, net earnings would have increased by $208,000. Effective January 1, 2002 the company also adopted the CICA recommendation for stock-based compensation and other stock-based payments. At present, the company does not expense stock options that are granted to employees and directors under stock and stock option plans with no cash settlement features. Had the company chosen to recognize the compensation, net earnings for the third quarter of 2002 would have decreased by $164,000 and by $247,000 for the first nine months. Outlook ------- In 1999, ZENON was awarded the contract to build what is currently the largest installed ultrafiltration drinking water plant for Olivenhain, California, producing 25 million gallons of water per day. Since quarter-end, the company announced a new 42 million gallon per day project to be built in Kamloops, British Columbia. Both are clear signals that membrane plants are becoming more prevalent and are increasing in size. When combined with the projects that are currently in ZENON's pipeline, management feels confident that it will continue to increase backlog. The financial results of the quarter also reflect management's ongoing focus on cost containment and profitability. "ZENON's future has never looked as bright and promising as it does today," concluded Mr. Benedek. "We have the right team and technology in place and are strategically positioned to take advantage of the increasing market opportunities." Conference Call and Webcast --------------------------- ZENON will hold a conference call on Wednesday, November 20, 2002 at 10:00 a.m. (EST) to discuss the company's financial results for the quarter and answer questions related to issues addressed in this release. To participate in the call, please dial 416-405-9328 five minutes prior to the 10:00 a.m. start. If you are unable to participate in the call at the scheduled time, you may listen to a replay by dialing 416-695-5800 then entering the pass code number 1308300. This service will be available through November 27, 2002. A live webcast of the conference call will also be available through the Investor Relations section of ZENON's website at www.zenonenv.com. ZENON is a world leader in providing advanced membrane products and services for water purification, wastewater treatment and water reuse to municipalities and industries worldwide. With hundreds of installations in over 30 countries, ZeeWeed(R) is Everywhere! Chosen as Canada's Top Exporter of the year, ZENON is also proud to be ranked as the country's Number One Corporate Citizen by Corporate Knights, a business publication addressing corporate social responsibility. For the third consecutive year, ZENON has been chosen as one of Canada's Top 100 Employers. The ZENON group of companies employs over 800 people who operate from seven locations in North America, six in Europe, and one in each of Asia, Latin America, and the Middle East. A S&P/TSX Composite company, ZENON Environmental Inc. trades under the symbols ZEN and ZEN.A. Additional information is available at the Company's web site www.zenonenv.com. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Nice numbers. Good luck to all
Bullboard Posts